Item
Number
with a
Comment
Percent
Agreeing
1. Research funding will decrease
4
100%
2. Clinical research will focus on outcome trials
4
100%
3. New drugs will be made
12
50%
4. New devices will be made (esp brain function)
9
56%
5. Molecular biology will be used in research
5
100%
6. The perioperative role of the anesthesiologist will increase
7
100%
7. Particularly in pain management
6
100%
8. A shortage of anesthesiologists will exist
8
88%
9. More non-anesthesiologists will deliver anesthesia
7
86%
10. Genetic testing will be used preoperatively
6
67%
11. Non-invasive monitoring will increase
5
100%
12. Checklists will guide clinical care
4
100%
13. Anesthetists will use electronic records
4
100%
14. Differences among countries in the quality of anesthesia will decrease
4
50%
New Drugs, Devices, and Safety
Fifty percent of editors discussing drug development predicted (item 3) a continuation of the 2000s when only one new drug (sugammadex) was introduced, pointing to the huge costs associated with new drug development, the relatively small market for anesthetic drugs, and of greatest importance, the proven efficacy and safety of currently available volatile agents, opioids, hypnotics, and neuromuscular blocking agents.